Search Results

Partnership will supply 14 essential medicines to US hospitals and patients

Kaiser Permanente, the nation’s largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond.

Civica Rx has announced that 12 health systems, representing approximately 250 hospitals across the United States, have joined the new not-for-profit generic drug company as founding members.

Marks first key milestone for the Civica Rx-Hikma partnership, which is set to supply 14 essential medicines to US hospitals and patients

Laura and John Arnold Foundation, Peterson Center on Healthcare and Gary and Mary West Foundation Each Commit $10 Million to New, Not-for-Profit Generic Drug Company

14 generic drugs used in hospitals are initial focus of efforts, CEO named

A new study provides the first empirical evidence that the not-for-profit manufacturer’s business model can lead to robust drug supplies and lower medicine costs.

At this time, Civica plans a recommended price to the consumer of no more than $30 per vial and no more than $55 for a box of five pen cartridges. It believes it can have these versions of insulin available by 2024.

18 BCBS companies to provide $55 million to help create a Civica subsidiary with the goal of bringing lower-cost, generic medications to individuals and families [23-January-2020] CHICAGO and SALT LAKE CITY , Jan. 23, 2020 /PRNewswire/ -- The Blue Cross Blue Shield Association (BCBSA), 18 independent and locally-operated Blue Cross and Blue Shiel

Today, Civica Rx announced a five-year deal with London, UK-based Hikma Pharmaceuticals to manufacture and supply Civica’s members with 14 sterile injectable drugs as a private label distributor.